Patents by Inventor Michael Cerreta

Michael Cerreta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS UTILIZING NFC TECHNOLOGY TO IMPLEMENT AN ON-DEMAND PORTABLE MEDICAL RECORD
    Publication number: 20090248437
    Abstract: In certain embodiments, an on-demand portable medical record system using near field communication includes a near field communication (NFC) storage device adapted to retrieve patient medical data for storage on the NFC storage device and a NFC retrieval device adapted to engage in near field communication with the NFC storage device to retrieve the patient medical data from the NFC storage device. An emergency on-demand portable medical record system using near field communication includes a NFC-enabled medical alert device storing a patient identifier, and a NFC retrieval device adapted to engage in near field communication with the NFC-enabled medical alert device to retrieve the patient identifier from the NFC storage device. The NFC-enabled medical alert device transfers the patient identifier to the NFC retrieval device via near field communication, and patient medical data is transferred to a medical facility upon verification of the patient identifier.
    Type: Application
    Filed: March 27, 2008
    Publication date: October 1, 2009
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Robert Gucciardi, Scott Michael Cerreta, Jeff Hutchinson, Jeff I. Chu, Ashish Vassa, Nikhil Jain, Priya Padate
  • Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one
    Patent number: 7309700
    Abstract: Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: December 18, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl A. Busacca, Michael Cerreta, Richard Varsolona, John Smoliga, Jon Lorenz, Jana Vitous
  • Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
    Publication number: 20050222134
    Abstract: Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one.
    Type: Application
    Filed: March 18, 2005
    Publication date: October 6, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Carl Busacca, Michael Cerreta, Richard Varsolona, John Smoliga, Jon Lorenz, Jana Vitous
  • Process for making a flowable nondigestible oil
    Publication number: 20050123665
    Abstract: A flowable nondigestible oil composition having a Consistency in a temperature range of 20° C. to 40° C. of less than about 600 P.sec(n?1). The flowable nondigestible oil contains a liquid polyol polyester having a complete melt point less than 37° C., and a solid polyol polyester having a complete melt point of at least about 37° C., wherein the solid polyol polyester contains a solid saturated polyol polyester capable of forming crystallized spherulites.
    Type: Application
    Filed: January 10, 2005
    Publication date: June 9, 2005
    Inventors: Michael Cerreta, Peter Lin, Penelope Edwards, Mark Agerton